You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API cetirizine hcl


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing cetirizine hcl

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Walgreens WAL-ZYR cetirizine hcl 0363-0921 FD&C YELLOW NO. 6
Walgreens WAL-ZYR cetirizine hcl 0363-0921 GELATIN
Walgreens WAL-ZYR cetirizine hcl 0363-0921 GLYCERIN
Walgreens WAL-ZYR cetirizine hcl 0363-0921 MANNITOL
Walgreens WAL-ZYR cetirizine hcl 0363-0921 POLYETHYLENE GLYCOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for cetirizine hcl

Excipient focus: ACESULFAME POTASSIUM

Excipient focus: ACETIC ACID

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BENZYL ALCOHOL

Excipient focus: BETADEX

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYLPARABEN

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

cetirizine hcl drug variants containing POLYETHYLENE GLYCOLS

Company Ingredient NDC
ASSURED (Greenbrier International Inc) cetirizine hcl 33992-0128
Care One (American Sales Company) cetirizine hcl 41520-129
LIVE BETTER (The Great Atlantic & Pacific Tea Company) cetirizine hcl 53187-129
LIVE BETTER (The Great Atlantic & Pacific Tea Company) cetirizine hcl 53187-220
Dolgencorp Inc (DOLLAR GENERAL & REXALL) cetirizine hcl 55910-220
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONES

cetirizine hcl drug variants containing POVIDONES

Company Ingredient NDC
ASSURED (Greenbrier International Inc) cetirizine hcl 33992-0128
LIVE BETTER (The Great Atlantic & Pacific Tea Company) cetirizine hcl 53187-129
LIVE BETTER (The Great Atlantic & Pacific Tea Company) cetirizine hcl 53187-220
Dolgencorp Inc (DOLLAR GENERAL & REXALL) cetirizine hcl 55910-220
P and L Development of New York Corporation cetirizine hcl 59726-220
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

Excipient focus: SORBITAN

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TOCOPHERYL NICOTINATE, D-.ALPHA.

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group